CPT2 and chronic kidney disease: Notably, in CKD, the diminished expression of CPT1 and CPT2 also results in decreased fatty acid oxidation, inadequate NADH generation, impaired electron transport chain (ETC) activity, depleted ATP levels, culminating in mitochondrial dysfunction (59).